A research vessel named Petrel has capsized in a dry dock in Leith, Edinburgh, causing injuries to 25 people.
A research vessel named Petrel has capsized in a dry dock in Leith, Edinburgh, causing injuries to 25 people.
Genedrive ® MT-RNR1 to commence roll out in Greater Manchester Project to follow NICE final recomendations scheduled for end of this month
Antibiotic Induced Hearing Loss test receives preliminary recommendation by NICE NICE enters public consultation phase of Early Value Assessment of the Genedrive® MT-RNR1 System
Genedrive file US FDA Pre-Submission for the Genedrive ® MT-RNR1 Product Range
MOSCOW: Ravil Maganov (chairman of Russia’s second-largest oil producer Lukoil) died today from a fall from a Moscow hospital window, according to Reuters.
genedrive plc (AIM: GDR), the near-patient molecular diagnostics company, announces that the UK’s National Institute for Health and Clinical Excellence (‘NICE’) has commenced an evaluation of CYP2C19 genotype testing for
genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that the UK Medicines and Healthcare Products Regulatory Agency has granted a CTDA enabling the sale of the Genedrive®
While you may be enjoying your weekend, there is a chance that Covid will still be in your thoughts. Residents of Shanghai, a city with 25 million inhabitants, will spend
NICE issues Medtech Innovation Briefing on Genedrive ® MT-RNR1 Test
World’s first point of care genetic test used to influence neonatal management in an acute setting and reduce aminoglycoside-induced hearing loss​​
First NHS Deployments of the Genedrive® System for Antibiotic Induced Hearing Loss